Brief: Miromatrix Announces FDA Clinical Hold On IND Application For miroliverELAP
14/12/2022 22:36
Dec 14 (Reuters) - Miromatrix Medical Inc MIRO.O :
* MIROMATRIX ANNOUNCES FDA CLINICAL HOLD ON IND APPLICATION
FOR
MIROLIVERELAP
* MIROMATRIX MEDICAL INC - FDA INDICATED THEY WILL PROVIDE
AN
OFFICIAL CLINICAL HOLD LETTER TO MIROMATRIX WITHIN 30 DAYS
Further company coverage: MIRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Miromatrix Medical
See all newsU.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
U.S. STOCKS ON THE MOVE-McDonald, Coherus BioSciences, Miromatrix,
Brief: Miromatrix To Pay United Therapeutics Termination Fee Of $4 Million In Connection With Termination Of Merger